Oxidized Carbon Black: Preparation, Characterization and Application in Antibody Delivery across Cell Membrane

Abstract Modulating biomolecular networks in cells with peptides and proteins has become a promising therapeutic strategy and effective biological tools. A simple and effective reagent that can bring functional proteins into cells can increase efficacy and allow more investigations. Here we show tha...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kittima Amornwachirabodee, Nattapol Tantimekin, Porntip Pan-In, Tanapat Palaga, Prompong Pienpinijtham, Chonlatip Pipattanaboon, Thanyada Sukmanee, Patcharee Ritprajak, Promchat Charoenpat, Pannamthip Pitaksajjakul, Pongrama Ramasoota, Supason Wanichwecharungruang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e95249bfc79b41049602cc37c7a66f0a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract Modulating biomolecular networks in cells with peptides and proteins has become a promising therapeutic strategy and effective biological tools. A simple and effective reagent that can bring functional proteins into cells can increase efficacy and allow more investigations. Here we show that the relatively non-toxic and non-immunogenic oxidized carbon black particles (OCBs) prepared from commercially available carbon black can deliver a 300 kDa protein directly into cells, without an involvement of a cellular endocytosis. Experiments with cell-sized liposomes indicate that OCBs directly interact with phospholipids and induce membrane leakages. Delivery of human monoclonal antibodies (HuMAbs, 150 kDa) with specific affinity towards dengue viruses (DENV) into DENV-infected Vero cells by OCBs results in HuMAbs distribution all over cells’ interior and effective viral neutralization. An ability of OCBs to deliver big functional/therapeutic proteins into cells should open doors for more protein drug investigations and new levels of antibody therapies and biological studies.